Harnessing CRISPR Technology for Viral Therapeutics and Vaccines: From Preclinical Studies to Clinical Applications
Description
The CRISPR/Cas system, identified as a type of bacterial adaptive immune system, have attracted significant attention due to its remarkable ability to precisely detect and eliminate foreign genetic material and nucleic acids. Expanding upon these
